Rowsley's third revival act in a decade should prompt caution
WHO doesn't love a company that's on the cusp of getting another shot at reinvigorating itself, huh? Such fascination, albeit premature at this point, led traders to lap up Singapore-listed Rowsley's stock last week after the company unveiled a ground-shifting all-share S$1.9 billion deal to revive its fortunes and move into the largely lucrative healthcare space.
But lest one forgets, this follows five years after the firm, controlled by billionaire Peter Lim, took its chance on a S$580 million transformational plan to inject a huge plot of waterfront land in Malaysia's then-booming Iskandar and one of Singapore's oldest architect firms RSP into the company.
Then, the reverse takeover deal aimed at turning the firm into a real estate bigwig had also galvanised the stock but alas till today, it has yet to live up to its lofty expectations.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Sanofi inks US$1.2 billion vaccine licensing deal with Novavax
Hin Leong founder OK Lim found guilty of 3 criminal charges
Ford CFO Lawler to step down in early 2025
Great Eastern shares jump 39% as OCBC mounts S$1.4 billion privatisation bid at S$25.60 per share
GuocoLand sells its stake in Eco World International for S$61 million
Genting Singapore nearly doubles Q1 net profit to S$247.4 million on CNY tourism spending